Hasan Körkaya
- Oncology top 0.5%
- Cancer Cells and Metastasis 32
- HER2/EGFR in Cancer Research 8
- Cancer-related Molecular Pathways 4
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 5
- Cancer, Hypoxia, and Metabolism 5
- Molecular Biology top 2%
- Epigenetics and DNA Methylation 7
- Immunology top 2%
- Immune cells in cancer 4
- Hepatology top 2%
-
- Monoclonal and Polyclonal Antibodies Research 4
- Co-authors
- Max S. WichaSuling LiuShawn G. ClouthierAmanda K. PaulsonChristophe GinestierSara A. CourtneidgePaul A. BromannGabriela Dontu
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (4 papers)Journal of Clinical Investigation (2 papers)
- Partner nations
- United StatesFranceIndia
In The Last Decade
Hasan Körkaya
62 papers receiving 7.0k citations
Hit Papers
Peers
Comparison fields: 5 of 122
- Oncology 4.1k
- Cancer Research 1.9k
- Molecular Biology 3.7k
- Immunology 1.1k
- Hepatology 340
Countries citing papers authored by Hasan Körkaya
This map shows the geographic impact of Hasan Körkaya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hasan Körkaya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hasan Körkaya more than expected).
Fields of papers citing papers by Hasan Körkaya
This network shows the impact of papers produced by Hasan Körkaya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hasan Körkaya. The network helps show where Hasan Körkaya may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hasan Körkaya, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2021 | 15 | |
| 3 | 2020 | 7 | |
| 4 | 2018 | 25 | |
| 5 | 2018 | 30 | |
| 6 | 2017 | 73 | |
| 7 | 2017 | 287 | |
| 8 | 2017 | 22 | |
| 9 | 2016 | 40 | |
| 10 | 2016 | 44 | |
| 11 | 2013 | 93 | |
| 12 | 2013 | 60 | |
| 13 | Activation of an IL6 Inflammatory Loop Mediates Trastuzumab Resistance in HER2+ Breast Cancer by Expanding the Cancer Stem Cell Populationbreakdown → | 2012 | 427 |
| 14 | 2012 | 31 | |
| 15 | Breast Cancer Stem Cells Are Regulated by Mesenchymal Stem Cells through Cytokine Networksbreakdown → | 2011 | 495 |
| 16 | 2010 | 443 | |
| 17 | 2009 | 388 | |
| 18 | PTEN and HER2 regulate self-renewal and invasion of human mammary stem cells. | 2007 | 1 |
| 19 | 2007 | 100 | |
| 20 | 2002 | 106 |
About Hasan Körkaya
Hasan Körkaya is a scholar working on Oncology, Cancer Research and Molecular Biology, having authored 63 papers that have together received 7.1k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (32 papers), HER2/EGFR in Cancer Research (8 papers), Epigenetics and DNA Methylation (7 papers), Cancer Genomics and Diagnostics (5 papers), Cancer, Hypoxia, and Metabolism (5 papers), Cancer-related Molecular Pathways (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Immune cells in cancer (4 papers). The work is most often cited by research in Oncology (4.1k citations), Cancer Research (1.9k citations) and Molecular Biology (3.7k citations). Hasan Körkaya has collaborated with scholars based in United States, France and India. Frequent co-authors include Max S. Wicha, Suling Liu, Shawn G. Clouthier, Amanda K. Paulson, Christophe Ginestier, Sara A. Courtneidge, Paul A. Bromann, Gabriela Dontu, Bryan Newman and Flora Iovino. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.